Elevai Labs, Common Stock Buy Hold or Sell Recommendation
| ELAB Stock | 1.99 0.11 5.24% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Elevai Labs, Common is 'Strong Sell'. Macroaxis provides Elevai Labs, buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ELAB positions.
Check out Elevai Labs, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Elevai and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Elevai Labs, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Elevai |
Execute Elevai Labs, Buy or Sell Advice
The Elevai recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Elevai Labs, Common. Macroaxis does not own or have any residual interests in Elevai Labs, Common or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Elevai Labs,'s advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Elevai Labs, Trading Alerts and Improvement Suggestions
| Elevai Labs, Common generated a negative expected return over the last 90 days | |
| Elevai Labs, Common has high historical volatility and very poor performance | |
| Elevai Labs, Common may become a speculative penny stock | |
| The company reported the previous year's revenue of 1.71 M. Net Loss for the year was (4.3 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Elevai Labs, generates negative cash flow from operations | |
| Elevai Labs, Common has a frail financial position based on the latest SEC disclosures | |
| About 73.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: Elevai Labs Inc. Executes 1-for-200 Reverse Stock Split |
Elevai Labs, Returns Distribution Density
The distribution of Elevai Labs,'s historical returns is an attempt to chart the uncertainty of Elevai Labs,'s future price movements. The chart of the probability distribution of Elevai Labs, daily returns describes the distribution of returns around its average expected value. We use Elevai Labs, Common price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Elevai Labs, returns is essential to provide solid investment advice for Elevai Labs,.
| Mean Return | -3.38 | Value At Risk | -31.03 | Potential Upside | 12.90 | Standard Deviation | 15.59 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Elevai Labs, historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Elevai Labs, Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Elevai Labs, or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Elevai Labs,'s price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Elevai stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -3.11 | |
β | Beta against Dow Jones | -2.69 | |
σ | Overall volatility | 15.54 | |
Ir | Information ratio | -0.22 |
Elevai Labs, Volatility Alert
Elevai Labs, Common is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Elevai Labs,'s stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Elevai Labs,'s stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Elevai Labs, Fundamentals Vs Peers
Comparing Elevai Labs,'s fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Elevai Labs,'s direct or indirect competition across all of the common fundamentals between Elevai Labs, and the related equities. This way, we can detect undervalued stocks with similar characteristics as Elevai Labs, or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Elevai Labs,'s fundamental indicators could also be used in its relative valuation, which is a method of valuing Elevai Labs, by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Elevai Labs, to competition |
| Fundamentals | Elevai Labs, | Peer Average |
| Return On Equity | -3.51 | -0.31 |
| Return On Asset | -0.89 | -0.14 |
| Profit Margin | (1.92) % | (1.27) % |
| Operating Margin | (2.32) % | (5.51) % |
| Current Valuation | 130.64 K | 16.62 B |
| Shares Outstanding | 3.07 M | 571.82 M |
| Shares Owned By Insiders | 72.97 % | 10.09 % |
| Shares Owned By Institutions | 18.19 % | 39.21 % |
| Number Of Shares Shorted | 2.62 M | 4.71 M |
| Price To Book | 0.75 X | 9.51 X |
| Price To Sales | 2.61 X | 11.42 X |
| Revenue | 1.71 M | 9.43 B |
| EBITDA | (4.27 M) | 3.9 B |
| Net Income | (4.3 M) | 570.98 M |
| Total Debt | 210.49 K | 5.32 B |
| Book Value Per Share | 0.22 X | 1.93 K |
| Cash Flow From Operations | (4.56 M) | 971.22 M |
| Short Ratio | 0.17 X | 4.00 X |
| Earnings Per Share | (88.92) X | 3.12 X |
| Number Of Employees | 18 | 18.84 K |
| Market Capitalization | 6.45 M | 19.03 B |
| Total Asset | 5.19 M | 29.47 B |
| Retained Earnings | (7.02 M) | 9.33 B |
| Working Capital | 3.62 M | 1.48 B |
| Net Asset | 5.19 M |
Note: Elevai Labs exotic insider transaction detected [view details]
Elevai Labs, Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Elevai . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Elevai Labs, Buy or Sell Advice
When is the right time to buy or sell Elevai Labs, Common? Buying financial instruments such as Elevai Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Elevai Labs, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Banking Thematic Idea Now
Banking
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Banking theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banking Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Elevai Labs, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevai Labs,. If investors know Elevai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevai Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (88.92) | Revenue Per Share 0.168 | Quarterly Revenue Growth 0.913 | Return On Assets (0.89) | Return On Equity (3.51) |
The market value of Elevai Labs, Common is measured differently than its book value, which is the value of Elevai that is recorded on the company's balance sheet. Investors also form their own opinion of Elevai Labs,'s value that differs from its market value or its book value, called intrinsic value, which is Elevai Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevai Labs,'s market value can be influenced by many factors that don't directly affect Elevai Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elevai Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Elevai Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevai Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.